109 related articles for article (PubMed ID: 6350777)
1. Failure of levamisole to restore in vitro lymphocyte responsiveness in lepromatous leprosy patients.
Reitan LJ; Belehu A
Lepr Rev; 1983 Jun; 54(2):153-5. PubMed ID: 6350777
[No Abstract] [Full Text] [Related]
2. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
Godal T; Myklestad B; Samuel DR; Myrvang B
Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies on the effect of levamisole in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation of neutrophils by suspensions of Mycobacterium leprae.
Goihman-Yahr M; Rodriguez-Ochoa G; Aranzazu N; Pinardi ME; de Gomez ME; Ocanto A; Convit J
Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):570-4. PubMed ID: 122626
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
7. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
8. An unusual case of untreated lepromatous leprosy with rare bacilli: an immunologic follow-up.
Gelber RH; Mohagheghpour N
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):353-4. PubMed ID: 3298482
[No Abstract] [Full Text] [Related]
9. The in vivo and in vitro effects of levamisole in patients with lepromatous leprosy.
Sher R; Wadee AA; Joffe M; Kok SH; Imkamp FM; Simson IW
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):159-66. PubMed ID: 7196885
[TBL] [Abstract][Full Text] [Related]
10. In vitro stimulation of lymphocytes with an antigen fraction prepared from Mycobacterium leprae and tuberculin PPD in contacts and non-contacts of leprosy patients.
Reitan LJ; Closs O
Clin Exp Immunol; 1984 Aug; 57(2):315-23. PubMed ID: 6380833
[TBL] [Abstract][Full Text] [Related]
11. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
12. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
Touw J; Stoner GL; Belehu A
Clin Exp Immunol; 1980 Sep; 41(3):397-405. PubMed ID: 6449337
[TBL] [Abstract][Full Text] [Related]
13. Selective loss of Mycobacterium leprae responsiveness of circulating lymphocytes in primary neuritic leprosy.
Nath I; Narayanan RB; Sathish M; Ahuja GK; Bhutani LK; Singh R
Lepr Rev; 1981 Mar; 52(1):79-89. PubMed ID: 7017320
[No Abstract] [Full Text] [Related]
14. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
15. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
Smelt AH; Rees RH; Liew FY
Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
[TBL] [Abstract][Full Text] [Related]
16. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
17. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
Rada EM; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
[No Abstract] [Full Text] [Related]
18. Influence of levamisole on lymphocytes and M. leprae in mice.
Ganguly NK; Kumar B; Kaur S; Vaishnavi C; Chakravarti RN
Indian J Lepr; 1985; 57(1):27-36. PubMed ID: 3839825
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the mechanism of immunological tolerance ("central failure") is operative in the lack of host resistance in lepromatous leprosy.
Godal T; Myrvang B; Froland SS; Shao J; Melaku G
Scand J Immunol; 1972; 1(4):311-21. PubMed ID: 4590279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
